This web only provides the extract of this article. If you want to read the figures and tables, please reference the PDF full text on Blackwell Synergy. Thank you.
- Original Article -
Expression and localization of CKLFSF2 in human spermatogenesis
Gang Liu1, Zhong-Cheng
Xin1, Liang Chen1, Long
Tian1, Yi-Ming Yuan1, Wei-Dong
Song1, Xue-Jun Jiang2, Ying-Lu Guo1
1Andrology Center of Peking University First Hospital, Beijing 100009, China
2Institute of Microbiology, Chinese Academy of Sciences, Beijing 100080, China
Abstract
Aim: To investigate the expression and subcellular localization of chemokine-like factor superfamily 2 (CKLFSF2) in
human testis and its potential role in spermatogenesis.
Methods: A specific polyclonal antibody against CKLFSF2
was raised. The expression and cellular localization of CKLFSF2 in the seminiferous tubules was checked by
immunohistochemistry method. Also,
in situ hybridization was applied to localize the mRNA distribution. The
EGFP-CKLFSF2 fusion protein was expressed in COS-7 cells to localize its subcellular location
in vitro. In addition, the abnormal expression of CKLFSF2 in testes of patients with male infertility was assayed by reverse transcription
polymerase chain reaction (RT-PCR) and immunohistochemistry methods.
Results: Having a close correlation with spermatogenesis defects, CKLFSF2 was specifically expressed in meiotic and post-meiotic germ cells, which were
localized to the endoplasmic reticulum (ER) near the Golgi apparatus.
Conclusion: CKLFSF2 could play important roles in the process of meiosis and spermiogenesis, and might be involved in the vesicular transport or membrane
apposition events in the endoplasmic reticulum.
(Asian J Androl 2007 Mar; 9: 189_198)
Keywords: spermatogenesis; testis; chemokine-like factor superfamily; infertility; endoplasmic reticulum
Correspondence to: Dr Zhong-Cheng Xin, Andrology Center of Peking University First Hospital, Beijing 100009, China.
Tel/Fax: +86-10-6618-2822
E-mail: xinzc@bjmu.edu.cn
Received 2006-07-20 Accepted 2006-11-06
DOI: 10.1111/j.1745-7262.2007.00249.x
1 Introduction
Mammalian spermatogenesis is a complex
phenome-non of cell differentiation, including mitotic stem cell
proliferation and meiosis, followed by remodeling of haploid
spermatids and progressing to the formation of mature
spermatozoa. It takes place within the germinal
epithelium of the seminiferous tubules. Abnormality of any
single step in spermatogenesis can cause male infertility.
Although, spermatogenesis has been extensively studied,
molecular details of this complex multistep
differentiation remain largely elusive.
Human chemokine-like factor superfamily (CKLFSF)
is a novel protein family that provides a structural and
functional link between chemokines and members of the
transmembrane 4 super family (TM4SF) [1, 2]. In humans, until now, nine genes encoding CKLF and
CKLFSF1-8 (CKLF-like MAL-related proteins for vesicle
trafficking and membrane link MARVEL transmembrane
domain containing1-8, CMTM1-8) have been cloned. Interestingly, most members of the CKLFSF family have
higher expression levels in testis, indicating they might
play systemic roles in spermatogenesis. Among members of the CKLFSF family, CKLFSF2 (CMTM2) is
highly expressed in testis, mainly in spermatogonia and
the seminiferous tubular fluid [3], which has four
putative transmembrane regions and a MARVEL domain. In
addition, CKLFSF2 is found to be very active during
evolution. In mice, CKLFSF2 has two counterparts,
mouse Cklfsf2a and Cklfsf2b [4]. Jeong et al. [5] reported a novel androgen receptor (AR) corepressor named
androgen receptor corepressor-19 kDa (ARR19) was expressed within seminiferous tubules and most
abundantly in germ cells, which is in fact the mouse Cklfsf2a.
This evidence suggests that human CKLFSF2 might have
an important function in spermatogenesis.
The aim of the present study was to analyze the
cellular localization of CKLFSF2 within human testes and
to characterize the potential role of CKLFSF2 in spermatogenesis.
2 Materials and methods
2.1 Samples
Informed consent was received from the participants
and the ethics committee of Peking University (China)
granted research approval prior to sample
collection. Testis tissue samples with different spermatogenesis
defect degrees were acquired via biopsy from azoospermia
patients aged 21_35 years. All testes samples were
acknowledged by pathologic diagnosis.
2.2 Preparation of the anti-CKLFSF2 polyclonal
antibody and specificity verification
2.2.1 Preparation of the anti-CKLFSF2 polyclonal
antibody
Polyclonal rabbit anti-CKLFSF2 serum was raised
against a synthetic peptide corresponding to the
N-terminal 15 amino acids (KPEEDKKDGKEPSDK) of the
cytoplamic tail of human CKLFSF2 plus an additional
cysteine residue at the C-terminus of the peptide.
The peptide was purchased from Biosynthesis Biotechnology
(Beijing, China), conjugated to keyhole limpet hemocyanin,
and emulsified with an equal volume of Freund complete
and incomplete adjuvants. It was then injected
subcutaneously into three New Zealand white rabbits at 50 µg in
1 mL every 2 weeks for 4 months. After confirming an
increase in the levels of antibody titer to more than × 5
000, the whole blood was collected from each rabbit and the
serum was separated. The IgG fraction was purified
from the serum using Affi-Gel 10 beads conjugated with
CKLFSF2 peptide and concentrated to approximately 100 µg/mL.
2.2.2 Specificity verification of the anti-CKLFSF2
polyclonal antibody
The specificity of the anti-CKLFSF2 polyclonal
antibody was verified by transient transfection and Western
blot analysis. First, the full-length coding sequences of
CKLFSF2 were cloned into the pcDNA3.1-Myc-HisB(-) mammalian expression vector (Invitrogen, Carlsbad, CA,
USA) to create pcDNA3.1-CKLFSF2/Myc-His6 (removed the stop codon) and pcDNA3.1-CKLFSF2 (reserved the
stop codon) as described in a previous report [3], and
COS-7 cells were maintained at 37ºC (5%
CO2) in Dulbecco modified eagle medium (DMEM) with 10%
fetal calf serum. Then, cells were transfected with
pcDNA3.1-CKLFSF2/Myc-His6 or pcDNA3.1-CKLFSF2 using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer's
instructions. The cells were collected 48 h after
transfection and cell lysates were subjected to Western blot
analysis with the anti-CKLFSF2 polyclonal antibody
(incubation overnight at 4ºC, 1 : 1 000TBST, 1% milk)
and the anti-Myc epitope antibody (incubation overnight
at 4ºC, 1 : 500TBST, 1% milk; Invitrogen, Carlsbad, CA,
USA) as described by Chen et al. [6].
2.3 Immunohistochemistry, immunopositive cell count
and statistical analysis
2.3.1 Immunohistochemistry
Immunohistochemistry experiments were carried out
to detect the cellular localization of CKLFSF2 in the
seminiferous tubules and its abnormal expression in
infertile patients' testes. After dewaxing and hydrating in
descending ethanols (100%, 95%, 80% and 70%), 8-µm
paraffin-embedded sections of human testis fixed in
Bouin's solution were washed in PBS (154 mmol/L NaCl,
10 mmol/L NaH2PO4, pH 7.5) and were treated with
0.3% H2O2 in methanol for 10 min to inhibit intrinsic
peroxidase activity and with 5% normal goat serum for
30 min to prevent nonspecific antibody binding.
Subsequently, the sections were then incubated
overnight at 4ºC with the anti-CKLFSF2 polyclonal antibody
at a 1 : 1 500 dilution in phosphate-buffered saline (PBS),
washed three times in PBS, and again incubated with
horseradish peroxidase (HRP) conjugated mouse
anti-rabbit IgG antibody for 1 h at room temperature.
Sections were washed twice in PBS and the bound antibody
was detected using DAB; control sections were stained
with pre-immune rabbit serum.
2.3.2 Immunopositive cell count and statistical analysis
The testis samples were divided into four pathologic
groups: normal spermatogenesis, spermatogenesis disturbance, spermatogenesis arrest and Sertoli cell-only
syndrome (SCOS). With three samples in each group,
CKLFSF2 positive cells were identified in 50
seminiferous tubules under a light microscope. Cells were scored
as CKLSFSF2-positive when they showed intensely dark
brown staining. Data were presented as mean ± SD of
CKLFSF2-positive cell number per seminiferous tubule.
To compare the significance of the means obtained from
pathologic groups, statistical analysis was carried out
using Kruskal_Wallis test and SPSS 13.0 for Windows
software (SPSS, Chicago, IL, USA). P < 0.05 was
considered to be statistically significant.
2.4 RNA extraction and RT-PCR
Total RNA of testis tissues was extracted with Trizol
reagent (Invitrogen) according to the manufacturer's
instructions, and reverse-transcribed to cDNA with Oligo
dT and avian myeloblastosis virus (AMV; Promega, Madison, WI, USA).
The CKLFSF2 specific primers sequences were as follows:
Upstream: 5'AGTCATGGCACCTAAGGCGGCAA3'
Downstream: 5'CCTCCAAGTCATTTCTTTCCC3'
The PCR product was 759 bp in size. Beta-actin
was used as the positive control. The reagents in 25 µL
PCR reaction systems were as follows:
H2O 17.75 µL, 10 × buffer 2.5 µL,
Mg2+ 1.5 µL, 10 mmol/L dNTP 1 µL,
Tag DNA polymerase 0.25 µL, upstream primer 10 pmol
0.5 µL, downstream primer 10 pmol 0.5 µL, and cDNA
sample 1 µL. PCR conditions used were as follows:
denaturation at 94ºC for 20 s, annealing at 59ºC for 20 s
and extension at 72ºC for 30 s. The first cycle had a
denaturation period of 3 min and the last cycle had an
extension period of 7 min. Thirty-five cycles of PCR
were carried out. The PCR products were analyzed by
1% (w/v) agarose gel electrophoresis.
2.5 In situ hybridization on paraffin sections of human
testis
In situ hybridization was applied to detect CKLFSF2
mRNA with a commercially available CKLFSF2 mRNA ISH detection kit. Digoxin (DIG)-labeled probe to
CKLFSF2 (oligo probe) was obtained from TBD Science Technology (Tianjin, China). The probe sequences
were as follows: 5'-TGAAG GGTAT GTATC TATGA ATGGC AAAGC-3'. A testis paraffin embedded section
of 5 µm thickness was incubated in 0.3% hydrogen
peroxide in methanol for 10 min and rinsed with PBS. After
exposed to proteinase K, prehybridization with
hybridization solution without the probe was carried out for
1 h at 37ºC. Then hybridization with a labeled probe
was carried out at 37ºC for 2 h. After hybridization, the
section was washed in 2 × standard saline citrate (SSC)
for three changes. Hybridized signal was detected with
AP-conjugated anti-DIG antibodies and visualized with
nitroblue tetrazolium and 5-bromo-4-chlro-3-indolyl
phatase.
2.6 Plasmid construction, cell transfection and
confocal microscopy
For analysis of the subcellular localization, the
full-length coding sequences of CKLFSF2 were cloned in
frame into the pEGFP-N1 and pECFP-N1 expression vectors (BD Biosciences Clontech, Frankin Lakes, NJ,
USA) to create pEGFP-N1-CKLFSF2 and pECFP-N1-CKLFSF2 as described previously [3]. The
recombinant plasmids were further confirmed by
dideoxynu-cleotide sequencing. COS-7 cells were maintained in
Dulbecco modified eagle medium (DMEM) containing 10% fetal bovine serum at 37ºC in 5%
CO2. The cells were transfected using lipofectamine 2000 (Invitrogen)
according to the manufacturer's instructions. Then, 24 h
after the cells transfected with GFP-CKLFSF2, ER and
Golgi apparatus were stained using ER-TrackerTM
Red (Molecular Probes; Invitrogern, Carlsbad, CA, USA) and
fluorescent BODIPY-TR ceraminde (Molecular Probes)
separately according to the manufacturer's protocol. In
our previous report [6], Cox7a2 was specifically
localized to mitochondria, so in the present study,
pEYFP-N1-Cox7a2 was co-transfected with pECFP-N1-CKLFSF2
to label the mitochondria. The treated cells were
visualized by laser confocal microscope (Leica, Wetzlar,
Germany).
3 Results
3.1 The specificity of the anti-CKLFSF2 antibody
Transient transfection and Western blot experiments
were carried out to analyze the specificity of the
anti-CKLFSF2 polyclonal antibody. The cell lysates of
COS-7 cells transfected with pcDNA3.1-CKLFSF2 (lane 1 in
Figure 1) were recognized only with the anti-CKLFSF2
antibody, whereas the cell lysates of COS-7 cells
transfected with pcDNA3.1-CKLFSF2/Myc-His6 to express
recombinant CKLFSF2 containing Myc epitope (lane 2
in Figure 1) were recognized with both the anti-CKLFSF2
and anti-Myc antibody. The molecular masses of detected bands were about 17kDa. No other band was
detected. This result confirmed the specificity of the
anti-CKLFSF2 antibody.
3.2 The CKLFSF2 protein was localized in a
stage-specific manner to the meiotic and post-meiotic germ cells
To confirm the cellular localization of CKLFSF2, we
carried out immunohistochemistry in paraffin-embedded
human testicular sections using the anti-CKLFSF2 antibody. The immunostaining was located exclusively
in the seminiferous tubules and was not detected in cells
of the interstitial tissue. Most seminiferous epithelia were
intensively immunostained in the cells at the periphery of
the lumen, mainly the round and elongating spermatids
(Figure 2a). However, in some seminiferous tubules,
the strong immunoactivity was detected in the pachytene
spermatocytes; the signal was concentrated in juxtanuclear cytoplasm, like the "cap" of the nucleus
(Figure 2b). For analysis of the specificity of the
reaction, we analyzed the same testis tissue sections
with preimmune serum (negative control). As expected,
staining with the preimmune serum showed no signal
(Figure 2c).
Furthermore, the localization of CKLFSF2 protein in
the cycle of the human seminiferous epithelium was
detected. As is already known, germ cells in different
phases of development are not randomly distributed within
the epithelium, but occur in a number of well-defined
and easily recognized combinations or associations. Six
well defined stages representing six different typical cell
associations can be recognized in the cycle of the human
seminiferous epithelium [7]. Detecting the localization
of CKLFSF2 in each stage could supply the kinetic
information during germ cell development. Here, at stage I,
CKLFSF2 signals dispersed in the tail cytoplasm of the
late elongating spermatids (Figure 2A); At stage II, with
the completion of the differentiation of the tail, the
spermatozoon was separated from the excess cytoplasm,
which remained in the epithelium as a residual body. At
this phase, CKLFSF2 immunoactivity appeared mainly in
the residual bodies and a little in the flagella of the mature
spermatozoa (Figure 2B); at stage III and IV, the CKLFSF2
signal appeared as a "dot" in the caudal part or postnuclear
region of round and early elongated spermatids (Figure
2C, 2D). At stage V and VI, the immunoactivity dispersed
in the tail cytoplasm of the more advanced generation of
elongating spermatids (Figure 2E, F). In brief, the
expression of CKLFSF2 protein showed specific
characteristics at different stages of the seminiferous
epithelium cycle.
In a kinetic view of germ cell development, the
immunostaining showed CKLFSF2 protein was first expressed in the cytoplasm of the pachytene spermatocytes;
then it appeared in the caudal part or post-nuclear region
when the spermatocytes differentiated into round and
early elongated spermatids, and further, in the late
elongating spermatids and mature spermatozoa, CKLFSF2
protein was localized to the tail cytoplasm and residual
bodies; During the whole cell differentiation process,
CKLFSF2 was never appeared in the nucleus or the acrosome. In conclusion, this result indicated the
protein of CKLFSF2 was localized in a stage-specific
manner to the meiotic and post-meiotic germ cells.
3.3 The CKLFSF2 mRNA was detected primarily in the
spermatocyte
In situ hybridization with a DIG-labelled antisense
riboprobe detected CKLFSF2 mRNA in the normal adult
testes. The CKLFSF2 mRNA was detected primarily in
the spermatocyte. No signal was detected in the spermatogonia, spermatids or the interstitial tissue (Figure
3A, 3C). Negative control using a sense probe showed
no hybridization signal in any cell type under identical
experimental conditions, confirming the specific
expression of CKLFSF2 mRNA (Figure 3B, 3D).
3.4 Differential expression of the CKLFSF2 protein in
the testes of patients with male infertility
Light microscopic immunohistochemistry showed the
expression of CKLFSF2 in different spermatogenesis
pathologic groups shown in Figure 4 (up panel). With
three samples in each group, CKLFSF2-positive cells
were identified in 50 seminiferous tubules under a
light microscope. As depicted in Figure 4
(graph), the number of CKLFSF2-positive cells per
seminiferous tubule in normal testes was the highest with
40.34 ± 12.75 (A), and was lower in
spermatogenesis disturbance testes with 22.40 ± 10.06 (B); the
number of CKLFSF2-positive cells per seminiferous tubule was the lowest in spermatogenesis arrest
testes with 8.44 ± 4.19 (C) and no CKLFSF2-positive
cells were found in the Sertoli cell-only syndrome
testis tissue (D). After a Kruskal_Wallis test,
statistically significant differences in the number of
CKLFSF2-positive cells per seminiferous tubule were found within
the pathologic groups (c2 = 108.84,
P < 0.01) and between every two spermatogenesis pathologic groups
(P < 0.01).
3.5 Abnormal expression of the CKLFSF2 mRNA in
infertile patients' testes
A total of 14 patients with azoospermia were included
in the present study. RT_PCR studies found no
detectable CKLFSF2 mRNA in patients with Sertoli cell-only
syndrome (1_6 in Figure 5) or in patients with
spermatogenesis arrest (7_9 in Figure 5); nevertheless, CKLFSF2
mRNA was detected in five patients diagnosed with
spermatogenesis disturbance (10_14 in Figure 5). The result
showed that CKLFSF2 is abnormally expressed in
infertile patients' testes.
3.6 CKLFSF2 fusion protein was localized to ER
apparatus
Laser confocal microscopy localized CKLFSF2 fusion protein to ER apparatus 24 h after transfection.
CKLFSF2 chimera appeared to be localized exclusively
in the membranous reticular structures in the perinuclear
region. In contrast, the GFP control protein as a control
was distributed homogeneously in the cytoplasm of the
COS-7 cells (data not shown). To further identify the
perinuclear compartment where CKLFSF2 fusion protein was localized, the transfected COS-7 cells were
stained with a fluorescent ER-specific probe
(ER-TrakerTM Red) and Golgi-specific probe (BODIPY TR
ceramide), or COS-7 cells were co-transfected with
CFP-CKLFSF2 and YFP-Cox7a2, a protein that is located in
the mitochondria [6]. It demonstrated that CKLFSF2
was co-localized with the ER marker and near the Golgi
apparatus, but not co-localized with Cox7a2 (Figure 6).
4 Discussion
In present study, we have investigated the cellular
localization of CKLFSF2 in the cycle of the seminiferous
epithelium, distribution of mRNA, subcellular
localization of its fusion protein, and its abnormal expression in
patients. These results strongly suggest that CKLFSF2
is localized in a stage-specific manner to the meiotic and
post-meiotic germ cells, and might play a crucial role in
the process of meiosis and spermiogenesis.
The present study differs from the previous study
[3], which only roughly stained CKLFSF2 in human testis,
as we have observed the expression of CKLFSF2 in the
whole cycle of the human seminiferous epithelium.
Immunohistochemistry techniques localized CKLFSF2 in a
stage-specific manner to meiotic and post-meiotic germ
cells (Figure 2); the staining initially appeared in pachytene
spermatocytes and persisted until mature spermatozoa,
mainly in the cytoplasm, but never in the acrosome. This
expression pattern largely revealed that CKLFSF2
actively participated in the meiotic and post-meiotic
process in spermatogenesis, but didn't play a part in the
formation of the acrosome.
In contrast, in situ hybridization revealed that
CKLFSF2 mRNA was only localized in the pachytene primary spermatocytes (Figure 3), which was not wholly
consistent with the aforementioned protein localization
in meiotic and post-meiotic germ cells. The discrepancy
might be due to two reasons: 1) the transcription of
CKLFSF2 mRNA terminates in the spermatocytes, whereas the translation of CKLFSF2 persists in the
subsequent spermatogenic stages by using the remaining
mRNA; 2) the transcription also stops in the
spermatocytes, but the protein remains and produces a marked effect in
the subsequent steps. Either way, the specific
localization of CKLFS2 mRNA in pachytene primary
spermatocytes indicated the involvement of CKLFSF2 gene in
spermatogenesis originated from the meiosis phase
concurrently with the protein. Similar splits between
transcription and translation are well recorded for certain
testis-specific proteins, such as the transition proteins
and the protamines [8], MC31/CE9 [9] and SgIGSF [10].
In addition, the importance of CKLFSF2 in
spermatogenesis was suggested by a close correlation between
CKLFSF2 abnormal expression and a spermatogenesis defect (Figures 4, 5). With the aggravation of the
spermatogenesis defect, the CKLFSF2-positive cell numbers
and mRNA level decreased significantly with no
expression in the testes of patients with SCOS, which is
characterized histologically by a complete loss of the
germinal epithelium in testicular tubules [11-13]. This
correlation, together with the cell- and stage-specific
expression, provided compelling evidence for a crucial
role of CKLFSF2 in spermatogenesis.
Although all of the above results indicated a close
relationship between CKLFSF2 and spermatogenesis, the exact function remains to be clarified. By confocal
microscopy, we observed that CKLFSF2 was localized
to the endoplasmic reticulum near the Golgi apparatus,
but not in mitochondria (Figure 6). As is known,
during the post-meiotic germ cell development, spermatids
undergo dramatic morphological transformations and
structural modifications of the Golgi apparatus, centriolar-axonemal complex, mitochondria and
endoplasmic reticulum [14]. In particular, the endoplasmic
reticulum is constituted by a multitude of membrane
tubules and vesicles, and undergoes a series of
morphological changes and disappears during the late stages
of spermiogenesis; this disappearance appears to have
an important role in the process of spermatid
differentiation [15, 16]. In addition, CKLFSF2 contains
MARVEL, a novel domain with a four transmembrane-helix architecture that has been identified in proteins of
the myelin and lymphocyte (MAL), physins, gyrins and
occluding families. Their function could be related to
cholesterol-rich membrane apposition events in a
variety of cellular processes, such as biogenesis of
vesicular transport carriers [17]. Taking all these together, it
is suggested that CKLFSF2 might participate in the
vesicular transport carriers or membrane apposition events
by sitting on ER.
Compared with a previous study [3], our results were
the extension and supplement to the characteristics of
CKLFSF2 in spermatogenesis. To the difference between
them, it may be due to many reasons, for example, the
trait difference of antibodies or the different tissue
sections. In summary, data presented in the current study
showed that CKLFSF2 was localized in a stage-specific
manner to the meiotic and post-meiotic germ cells and
had a close correlation with spermatogenesis defects, so
it could play important roles in the process of meiosis
and spermiogenesis. The function of CKLFSF2 might
be involved in the vesicular transport carriers or
membrane apposition events by sitting on ER. Further study
is needed to address the specific role of CKLFSF2 in ER
apparatus-regulated spermatogenesis.
Acknowledgment
This work was supported by grants from National
Natural Science Foundation of China (No. 30471729) and
the "211" Project of the "Tenth-Five" Program for Peking
University Health Science Center, China (No. 219).
References
1 Wang L, Wu C, Zheng Y, Qiu X, Wang L, Fan H,
et al. Molecular cloning and characterization of chemokine-like factor
1 (CKLF1), a novel human cytokine with unique structure
and potential chemotactic activity. Biochem J 2001; 357:
127_35.
2 Han W, Ding P, Xu M, Wang L, Rui M, Shi S,
et al. Identification of eight genes encoding chemokine-like factor
superfamily members 1_8 (CKLFSF1_8) by in silico cloning and
experimental validation. Genomics 2003; 81: 609_17.
3 Shi S, Rui M, Han W, Wang Y, Qiu X, Ding P,
et al. CKLFSF2 is highly expressed in testis and can be secreted into the
seminiferous tubules. Int J Biochem Cell Biol 2005; 37: 1633_40.
4 Li T, Han W, Ding P, Ding P, Rui M, Liu D,
et al. Molecular cloning and identification of mouse
Cklfsf2a and Cklfsf2b, two homologues of
human CKLFSF2. Int J Biochem Cell Biol 2006; 38: 420_9.
5 Jeong BC, Hong CY, Chattopadhyay S, Park JH, Gong EY,
Kim HJ, et al. Androgen receptor corepressor-19 kDa
(ARR19), a leucine-rich protein that represses the
transcriptional activity of androgen receptor through recruitment of
histone deacetylase. Mol Endocrinol 2004; 18: 13_25.
6 Chen L, Xin ZC, Li X, Tian L, Yuan YM, Liu G,
et al. Cox7a2 mediates steroidogenesis in TM3 mouse Leydig cells. Asian J
Androl 2006; 8: 589_94
7 Clermont Y. The cycle of the seminiferous epithelium of man.
Am J Anat 1963; 112: 35_51.
8 Hecht NB. Gene expression during male germ cell development.
In: Desjardins C, Ewing LL. Cell and Molecular Biology of the
Testis. New York: Oxford University Press; 1993: 400_32.
9 Wakayama T, Nagata K, Ohashi K, Mizuno K, Tanii I,
Yoshinaga K, et al. The expression and cellular localization of
the sperm flagellar protein MC31/CE9 in the rat testis:
possible post transcriptional regulation during rat spermatogenesis.
Arch Histol Cytol 2000; 63: 33_41.
10 Wakayama T, Koami H, Ariga H, Kobayashi D, Sai Y, Tsuji A,
et al. Expression and functional characterization of the
adhesion molecule spermatogenic immunoglobulin superfamily in
the mouse testis. Biol Reprod 2003; 68: 1755_63.
11 Friedrich M, Grahnert A, Paasch U, Tannapfel A, Koch-Nolte
F, Hauschildt S. Expression of toxin-related human
mono-ADP-ribosyltransferase 3 in human testes. Asian J Androl
2006; 8: 281_7.
12 Weikert S, Christoph F, Schulze W, Krause H, Kempkensteffen
C, Schostak M, et al. Testicular expression of survivin and
human telomerase reverse transcriptase (hTERT) associated
with spermatogenic function in infertile patients. Asian J Androl
2006; 8: 95_100.
13 Zhang XD, Yin LL, Zheng Y, Lu L, Zhou ZM, Sha JH.
Expression of a novel beta adaptin subunit mRNA splice variant
in human testis. Asian J Androl 2005; 7: 179_88.
14 Clermont Y, Oko R, Hermo L. Cell biology of mammalian
spermiogenesis. In: Desjardins C, Ewing LL. Cell and
Molecular Biology of the Testis. New York: Oxford University Press;
1993: 332_76.
15 Clermont Y, Rambourg A. Evolution of the endoplasmic
reticulum during rat spermiogenesis. Amer J Anat 1978; 151:
191_212.
16 Nakamoto T, Sakai Y. Changes in endoplasmic reticulum
during spermiogenesis in the mouse. Cell Tiss Res 1989; 257:
279_84.
17 Sanchez-Pulido L, Martin-Belmonte F, Valencia A, Alonso
MA. MARVEL: a conserved domain involved in membrane
apposition events. Trends Biothem Sci 2002; 27: 599_601. |